Key takeaway
In a 16-week randomized trial of 244 overweight adults in Washington, DC, body weight fell by 5.9 kg (95% CI 5.0-6.7 kg; P < .001) on a low-fat vegan diet, with improved insulin sensitivity and less liver and muscle fat; none of these changed significantly in the control group. Participants knew their group and were mostly women (87%), so results may not apply to everyone.
Study design
Randomised trial
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
The research question
Excess weight and insulin resistance lead to type 2 diabetes and other major problems, so effective diets are needed. The authors tested how a low-fat vegan diet changes body weight, insulin resistance, the energy burned after a meal and fat stored in liver and muscle in overweight adults.
Who and how
Randomized clinical trial in Washington, DC, from January 2017 to February 2019. Of 3115 people who responded to advertisements, 244 aged 25 to 75 with a body mass index of 28 to 40 were randomized 1:1 to a low-fat vegan diet (n = 122) or to make no diet changes (n = 122) for 16 weeks. Weight was measured on a calibrated scale, body composition and visceral fat by dual x-ray absorptiometry, insulin resistance by the homeostasis model assessment index and the predicted insulin sensitivity index (PREDIM), and the thermic effect of food by indirect calorimetry over 3 hours after a 720 kcal liquid breakfast. In a subset (n = 44), liver and muscle lipids were measured by proton magnetic resonance spectroscopy. Repeated measure analysis of variance was used.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Of 244 participants, 211 (87%) were female and 117 (48%) White; mean age was 54.4 years (SD 11.6). Body weight fell by 5.9 kg (95% CI 5.0-6.7 kg; P < .001) in the vegan diet group.
- 2The thermic effect of food, the extra energy burned digesting a meal, rose by 14.1% (95% CI 6.5-20.4; P < .001). Insulin resistance by the homeostasis model assessment index decreased (-1.3; 95% CI -2.2 to -0.3; P < .001) and PREDIM, a measure of insulin sensitivity, increased (0.9; 95% CI 0.5-1.2; P < .001).
- 3In the 44-person subset, liver (hepatocellular) lipid fell by 34.4%, from a mean of 3.2% (SD 2.9%) to 2.4% (2.2%) (P = .002), and muscle (intramyocellular) lipid by 10.4%, from 1.6 (1.1) to 1.5 (1.0) (P = .03). None of these variables changed significantly in the control group.
- 4A bigger weight loss went with a bigger PREDIM improvement (r = -0.43; P < .001), and changes in liver and muscle lipid tracked changes in insulin resistance (both r = 0.51; P = .01).
Limits & uncertainty
- 1The control group was told to make no diet changes and there was no blinding or alternative diet, so expectations and attention may have contributed.
- 287% of participants were women and the sample volunteered through advertisements, so results may not carry over to men or the wider population.
- 3Liver and muscle fat were measured in only 44 people, and their correlations come from small numbers.
- 4The abstract does not say whether the weight loss lasted beyond 16 weeks, and the explanation that the diet lowered energy intake is the authors' interpretation. This reading is based on the abstract only.
What to take from it
For overweight adults, a low-fat plant-based diet followed for 16 weeks was linked to meaningful weight loss and better insulin sensitivity compared with no change. The trial cannot say whether the benefit comes from being vegan, from low fat or simply from eating less. Anyone with diabetes or on medication should talk to their clinician before changing their diet.
Reading your own data
Body weight is the easiest measure to follow: weigh at the same time of day on the same scale and look at weekly averages. Food logs show whether energy intake is falling. Insulin sensitivity and liver fat need lab or imaging tests, though fasting glucose or a CGM trend can add context.
How to read this evidence
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Importance
Excess body weight and insulin resistance lead to type 2 diabetes and other major health problems. There is an urgent need for dietary interventions to address these conditions.
Objective
To measure the effects of a low-fat vegan diet on body weight, insulin resistance, postprandial metabolism, and intramyocellular and hepatocellular lipid levels in overweight adults.
Design, setting, and participants
This 16-week randomized clinical trial was conducted between January 2017 and February 2019 in Washington, DC. Of 3115 people who responded to flyers in medical offices and newspaper and radio advertisements, 244 met the participation criteria (age 25 to 75 years; body mass index of 28 to 40) after having been screened by telephone.
Interventions
Participants were randomized in a 1:1 ratio. The intervention group (n = 122) was asked to follow a low-fat vegan diet and the control group (n = 122) to make no diet changes for 16 weeks.
Main outcomes and measures
At weeks 0 and 16, body weight was assessed using a calibrated scale. Body composition and visceral fat were measured by dual x-ray absorptiometry. Insulin resistance was assessed with the homeostasis model assessment index and the predicted insulin sensitivity index (PREDIM). Thermic effect of food was measured by indirect calorimetry over 3 hours after a standard liquid breakfast (720 kcal). In a subset of participants (n = 44), hepatocellular and intramyocellular lipids were quantified by proton magnetic resonance spectroscopy. Repeated measure analysis of variance was used for statistical analysis.
Results
Among the 244 participants in the study, 211 (87%) were female, 117 (48%) were White, and the mean (SD) age was 54.4 (11.6) years. Over the 16 weeks, body weight decreased in the intervention group by 5.9 kg (95% CI, 5.0-6.7 kg; P < .001). Thermic effect of food increased in the intervention group by 14.1% (95% CI, 6.5-20.4; P < .001). The homeostasis model assessment index decreased (-1.3; 95% CI, -2.2 to -0.3; P < .001) and PREDIM increased (0.9; 95% CI, 0.5-1.2; P < .001) in the intervention group. Hepatocellular lipid levels decreased in the intervention group by 34.4%, from a mean (SD) of 3.2% (2.9%) to 2.4% (2.2%) (P = .002), and intramyocellular lipid levels decreased by 10.4%, from a mean (SD) of 1.6 (1.1) to 1.5 (1.0) (P = .03). None of these variables changed significantly in the control group over the 16 weeks. The change in PREDIM correlated negatively with the change in body weight (r = -0.43; P < .001). Changes in hepatocellular and intramyocellular lipid levels correlated with changes in insulin resistance (both r = 0.51; P = .01).
Conclusions and relevance
A low-fat plant-based dietary intervention reduces body weight by reducing energy intake and increasing postprandial metabolism. The changes are associated with reductions in hepatocellular and intramyocellular fat and increased insulin sensitivity.
Trial registration
ClinicalTrials.gov Identifier: NCT02939638.
Sources & attribution
Effect of a Low-Fat Vegan Diet on Body Weight, Insulin Sensitivity, Postprandial Metabolism, and Intramyocellular and Hepatocellular Lipid Levels in Overweight Adults: A Randomized Clinical Trial.
Kahleova H, Petersen KF, Shulman GI, Alwarith J, Rembert E, Tura A, Hill M, Holubkov R, Barnard ND.
JAMA network open · 2020-11-02
DOI: 10.1001/jamanetworkopen.2020.25454 ↗PubMed · 33252690 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

